Viewing nowCombinationLevobalsartan Tablet 2.5/160 mg
Valsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
AhnGuk New Pharm Co., Ltd.

MFDS item code 201903024 · Approved 2019.05.10 · Insurance code 053601210
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using S-Amlodipine (Amlodipine) or Valsartan. It helps to lower and control blood pressure, thereby reducing the risk of cardiovascular complications. It effectively aids patients who have difficulty in managing hypertension to control their blood pressure. Regular intake contributes to maintaining healthy blood pressure levels. It is used for the treatment of essential hypertension due to these benefits.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take the tablet at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ 2.5/80 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 80 milligrams. ㆍ 2.5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with S-amlodipine 2.5 milligrams (amlodipine 5 milligrams) or valsartan 160 milligrams. ㆍ 5/160 milligrams: For patients whose blood pressure is not adequately controlled with monotherapy with S-amlodipine 5 milligrams (amlodipine 10 milligrams) or valsartan 160 milligrams, or with 2.5/160 milligrams. Patients taking valsartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients receiving dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients allergic to the active ingredients or similar medications, pregnant or nursing women, individuals with severe kidney or liver disease, and those with certain heart conditions should not take this medication. Patients with sodium or fluid depletion may experience hypotension, so their condition should be carefully assessed prior to use, and blood pressure and status should be closely monitored during treatment. Patients with high potassium levels or those taking potassium-containing medications should have their potassium levels checked regularly, and caution is needed for patients with poor kidney function. Renal transplant recipients or those with a history of angioedema may face risks when taking this medication, requiring special attention. Patients with heart failure or post-myocardial infarction should have their kidney function and blood pressure regularly evaluated while on this medication, and some heart disease patients should exercise caution when using it. The risk of hypotension, worsening kidney function, and hyperkalemia may increase when this medication is taken in conjunction with other antihypertensives, so it should be taken under medical supervision. Side effects such as dizziness, headache, edema, rash, and cough may occur; if any unusual symptoms arise, consultation with a healthcare professional is advised. Dizziness or fatigue may occur when driving or operating machinery, so caution is warranted. Women who are pregnant or planning to become pregnant should not take this medication, and it is also not recommended for nursing mothers. The safety and efficacy of this medication have not been established in children under 18 years of age, so it is not recommended for this population. Severe hypotension or heart abnormalities may occur in cases of overdose, so it is important to comply with the prescribed dosage, and in case of overdose, seek immediate medical attention.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasm, weakness, polyuria, nocturia, erectile dysfunction, edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, hemoglobin decrease, hematocrit decrease, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, renal damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorder, enuresis, gynecomastia, pain, lethargy, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurosensitivity, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to keep it at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer period.
Dark yellow rectangular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
AhnGuk New Pharm Co., Ltd.
CombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 80mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
AhnGuk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Ahn-Gook New Pharm Co., Ltd.
CombinationValsartan 80mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Anguk New Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.